CMS has clarified that providers may no longer bill Medicare for wastage associated with the use of non-BLA skin substitute products as of January 1. The JZ and JW Modifiers should no longer be used for skin substitute application for Medicare beneficiaries.
Following APMA's formal request in October 2025, the Centers for Medicare and Medicaid Services (CMS) released an updated version (Version 3.0) of the WISeR Model Provider and Supplier Operational Guide which removes CPT® 11042 (debridement of subcutaneous tissue) from Appendix B.
Starting April 1, when the same provider bills an E/M service and a global radiology code for the same patient on the same date, UnitedHealthcare will require a full written interpretation and report to separately reimburse the professional component of the radiology service. If no written report is submitted, the professional component of the global radiology code will not be reimbursed separately and time spent reviewing the radiology images will be bundled into the payment for the E/M service.
State component leaders can apply for new grant opportunities through October 1, 2026.
Survey on PRP for Diabetic Wounds
|
APMA encourages responses to The Alliance for Wound Care Stakeholders' survey by September 1, but responses may be submitted through December 31. |
Make your voice heard. Join the upcoming listening session on Monday, August 31, 8:00 p.m. ET.
Read our recent comment letter supporting S. 5180, the Provider Reimbursement Stability Act.
Meet the 2026 Abstract Competition WinnersAPMA congratulates the winners of this year's Poster and Oral Abstract Competitions, presented at the 2026 Annual Scientific Meeting. |
Help recognize an APMA member who has made an outstanding contribution to podiatry! Nominations open through September 28.